Pharmaceuticals

Bristol Myers Squibb is one of the most important commercial cell therapy developers globally, with approved CAR-T therapies in hematologic malignancies and a major presence in multiple myeloma and lymphoma. Its cell therapy platform was significantly strengthened through its acquisition of Celgene, which brought key cellular therapy assets and infrastructure.

BridgeBio Pharma is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biotechnology Firms 2 ranking categories Overview

Zevra Therapeutics is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Rare Disease & Orphan Drug Developers 1 ranking category Overview

Boehringer Ingelheim is one of the world’s largest privately held pharmaceutical companies and remains an important global player in cardiometabolic medicine, respiratory disease, immunology, oncology, and animal health. Its private ownership gives it a distinctive strategic profile compared with publicly listed pharmaceutical companies.

Blueprint Medicines is a precision medicine company with a meaningful rare disease profile through systemic mastocytosis and related kinase-driven disorders. The company focuses on targeted medicines for genomically or biologically defined diseases, including rare hematologic and mast-cell conditions.

Xenon Pharmaceuticals is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Rare Disease & Orphan Drug Developers 1 ranking category Overview

WuXi Biologics is one of the leading global biologics CRDMO providers, offering end-to-end services across biologics discovery, development, clinical manufacturing, commercial manufacturing, and regulatory support. Its integrated research-development-manufacturing model gives it a differentiated position in the biologics outsourcing market.

Worldwide Clinical Trials is a mid-sized global CRO focused on full-service clinical development across therapeutic areas including neuroscience, oncology, rare disease, cardiovascular disease, and metabolic disorders. It serves pharmaceutical and biotechnology sponsors seeking a more specialized alternative to the largest CRO platforms.

WCG Clinical occupies a specialized but important position within the CRO ecosystem. It is best known for institutional review board services, ethical review, study start-up support, clinical trial technology, endpoint services, and site-related trial infrastructure.

Walvax Biotechnology is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Vaccine & Immunotherapy Developers 1 ranking category Overview

Vor Biopharma is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Cell & Gene Therapy Developers 1 ranking category Overview

Viatris is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Global Pharmaceutical Companies 1 ranking category Overview

Vetter is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biomanufacturing & CDMO Providers 1 ranking category Overview

Verve Therapeutics is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Cell & Gene Therapy Developers 1 ranking category Overview

Vertex Pharmaceuticals is one of the most strategically important biotechnology firms globally, with a dominant position in cystic fibrosis and expanding activity in gene editing, pain medicine, kidney disease, and other genetically or biologically defined conditions.

Veristat is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Contract Research Organizations 1 ranking category Overview

Vaxcyte is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biotechnology Firms 2 ranking categories Overview

Valneva is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Vaccine & Immunotherapy Developers 1 ranking category Overview

United Therapeutics is an established biotechnology firm focused on pulmonary arterial hypertension and related rare cardiopulmonary diseases, with additional long-term activity in organ manufacturing and transplant-related technologies.

uniQure is one of the pioneering companies in gene therapy, with a history in AAV-based therapeutic development. The company is associated with some of the earliest gene therapy milestones in Europe and has remained active in hemophilia and neurological gene therapy.